ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
0.088
0.00
(0.00%)
Cerrado 17 Noviembre 11:00PM

Herramientas de nivel profesional para inversores individuales.

BEM Noticias

Solo noticias oficiales
Se encontraron 0 artículos
MightyX MightyX 2 minutos hace
That’s what lotto refers to..3-6months(mindset)is for trading..1yr+ is investing
TPTW
02opida 02opida 3 minutos hace
MILIF - Military Metals Completes Acquisition of Brownfield Antimony Projects in Europe
MILIF
02opida 02opida 3 minutos hace
ACET - Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
ACET
02opida 02opida 3 minutos hace
ACET - Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
ACET
02opida 02opida 3 minutos hace
CYTK - Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
CYTK
02opida 02opida 4 minutos hace
Sunday Hi Everyone :)
02opida 02opida 4 minutos hace
LLY - Lilly's tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity
LLY
02opida 02opida 4 minutos hace
NTLA - Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis
NTLA
02opida 02opida 5 minutos hace
BMRN - BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO(TM) (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
BMRN
02opida 02opida 5 minutos hace
MAT - Hot Wheels Crowns 2024 Global Legends Tour Winner, Soon to be Reimagined as a Hot Wheels Die-Cast Car Sold Worldwide
02opida 02opida 5 minutos hace
BSX - Boston Scientific WATCHMAN FLX(TM) Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial
BSX
Torez Torez 5 minutos hace
So you should know with you fancy MBA that there is too much supply of shiba, what was it again over 500 trillions??? 
SHIBUSD
02opida 02opida 5 minutos hace
ZHUD - Zhuding International Limited Signs Reverse Merger Agreement with Automated Water Solutions Inc. and Belisarian Holdings
ZHUD
Seminole Red Seminole Red 6 minutos hace
Inauguration is next, then China stops there BS
Konaploinks Konaploinks 8 minutos hace
This year, a dedicated quantum track and pavilion will be featured in the exhibit hall, spotlighting advancements in quantum computing. IonQ will be offering a preview of some of its newest innovations in hybrid quantum-classical computing, built to enable the development and deployment of quantum-a
IONQ
SniffinPennies SniffinPennies 11 minutos hace
I'm sure, A broken clock is always right twice a day, When then merger is completed, and this company gets on track I'm sure there will be posters on this sites boards he trolls to make them aware(if there not already) what a stock scamming manipulator he is and point out he's not to be believed and
CGAC
cottonmather cottonmather 12 minutos hace
Harry's Rant Nov 15. 11 minutes https://www.youtube.com/watch?v=mKk2FIIvyfE
The ELTP King The ELTP King 13 minutos hace
Purdue Pharma L.P. et al v. Accord Healthcare Inc.

Friday, November 15, 2024

18 - MOTION to Withdraw as Attorney Madison B. Waller filed by Purdue Pharma L.P.
19 - MOTION to Withdraw as Attorney Gavin B. Parsons filed by Accord Healthcare Inc.
20 - Notice
ELTP
dennisdave dennisdave 21 minutos hace
theorysuit said:
there is no contract vs NWBO last 10Q
The Company completed negotiations and entered into a contract with a company that has a complementary immunotherapy agent, and the two companies have been engaged for a number of months in joint development of trial designs
NWBO
LLnEorBust LLnEorBust 33 minutos hace
Most of the fees are earned in pre-trial discovery and motion practice. Other costs are added on top of whatever the contingency would be--in this case they had a forensic accountant and a reserve engineer do very extensive reviews.

But, I don't know if this would have been a conting
Jasbg Jasbg 33 minutos hace
Slever, You may call it whining - I call it laying out the facts: 'I own 62.000 shares - have lost what could buy me +6 new Tesla 3 cars' - FACTS !!
---------------------

What are your Facts: How many shares ? How much under in dollars ? You know honest FACTS ?
-----
AMRN
SkeBallLarry SkeBallLarry 36 minutos hace
" LOL .. !! . Countdown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
kabunushi kabunushi 39 minutos hace
I had responded to a thread discussing a different paragraph of the 10Q, from which I quoted. That has nothing to do with any of the Roswell trials but rather concerns NW's contract with the unnamed owner of an unnamed different agent, to jointly develop a clinical trial to test their agent in combi
NWBO
duderaja duderaja 39 minutos hace
Did you see who Trump appointed to head up the dept. of energy?
FCEL
SkeBallLarry SkeBallLarry 40 minutos hace
" Capgain ~ G'Morning to youz " .. !!

Su Consulta Reciente

Delayed Upgrade Clock